Session

H. pylori (Posters)

VONOPRAZAN-AMOXICILLIN DUAL THERAPY FOR H. PYLORI INFECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS
VONOPRAZAN-AMOXICILLIN DUAL THERAPY FOR H. PYLORI INFECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS

H. pylori (Posters)  et al.

EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG): CLINICAL PHENOTYPES THROUGH MACHINE LEARNING OF FIRST-LINE TREATED PATIENTS IN SPAIN DURING THE PERIOD 2013-2018
EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG): CLINICAL PHENOTYPES THROUGH MACHINE LEARNING OF FIRST-LINE TREATED PATIENTS IN SPAIN DURING THE PERIOD 2013-2018

H. pylori (Posters)  et al.

CLARITHROMYCIN RESISTANCE IS MORE COMMON AMONG LESS VIRULENT HELICOBACTER PYLORI STRAINS - DATA FROM AN IRISH CENTRE
CLARITHROMYCIN RESISTANCE IS MORE COMMON AMONG LESS VIRULENT HELICOBACTER PYLORI STRAINS - DATA FROM AN IRISH CENTRE

H. pylori (Posters)  et al.

REAL-WORLD COMPARATIVE EFFECTS OF THREE-IN-ONE SINGLE CAPSULE BISMUTH QUADRUPLE THERAPY VS. NON-BISMUTH QUADRUPLE CONCOMITANT THERAPY: INTERIM ANALYSIS OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
REAL-WORLD COMPARATIVE EFFECTS OF THREE-IN-ONE SINGLE CAPSULE BISMUTH QUADRUPLE THERAPY VS. NON-BISMUTH QUADRUPLE CONCOMITANT THERAPY: INTERIM ANALYSIS OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

H. pylori (Posters)  et al.

THE LONG-TERM EFFECT OF THE ERADICATION OF HELICOBACTER PYLORI IN T2DM OR PREDM PATIENTS
THE LONG-TERM EFFECT OF THE ERADICATION OF HELICOBACTER PYLORI IN T2DM OR PREDM PATIENTS

H. pylori (Posters)  et al.

PERSONALISED MEDICINE: IS THIS THE WAY TO COMBAT HELICOBACTER PYLORI (HP) ERADICATION FAILURE?
PERSONALISED MEDICINE: IS THIS THE WAY TO COMBAT HELICOBACTER PYLORI (HP) ERADICATION FAILURE?

H. pylori (Posters)  et al.

H.PYLORI INFECTION AND NUTRITIONAL STATUS IN END-STAGE RENAL DISEASE PATIENTS
H.PYLORI INFECTION AND NUTRITIONAL STATUS IN END-STAGE RENAL DISEASE PATIENTS

H. pylori (Posters)  et al.

APPLICATION OF OLGA AND OLGIM STAGING SYSTEMS IN HP GASTRITIS
APPLICATION OF OLGA AND OLGIM STAGING SYSTEMS IN HP GASTRITIS

H. pylori (Posters)  et al.

STABLE RATE OF HELICOBACTER PYLORI INFECTION IN PATIENTS WITH PEPTIC ULCER DISEASE IN A TERTIARY REFERRAL HOSPITAL OVER THE LAST DECADE
STABLE RATE OF HELICOBACTER PYLORI INFECTION IN PATIENTS WITH PEPTIC ULCER DISEASE IN A TERTIARY REFERRAL HOSPITAL OVER THE LAST DECADE

H. pylori (Posters)  et al.

BISMUTH QUADRUPLE REGIMEN WITH TETRACYCLINE OR DOXYCYCLINE VERSUS PYLERA® AS THIRD-LINE RESCUE THERAPY FOR H. PYLORI INFECTION: A PROSPECTIVE MULTICENTER ANALYSIS OF THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)
BISMUTH QUADRUPLE REGIMEN WITH TETRACYCLINE OR DOXYCYCLINE VERSUS PYLERA® AS THIRD-LINE RESCUE THERAPY FOR H. PYLORI INFECTION: A PROSPECTIVE MULTICENTER ANALYSIS OF THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)

H. pylori (Posters)  et al.

HELICOBACTER PYLORI SCREENING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
HELICOBACTER PYLORI SCREENING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION

H. pylori (Posters)  et al.

ENDOSCOPIC YIELD OF CHRONIC EPIGASTRIC PAIN SYNDROME IN OUTPATIENTS
ENDOSCOPIC YIELD OF CHRONIC EPIGASTRIC PAIN SYNDROME IN OUTPATIENTS

H. pylori (Posters)  et al.

EFFECTIVENESS OF FIRST-LINE HELICOBACTER PYLORI ERADICATION TREATMENTS IN SPAIN: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EFFECTIVENESS OF FIRST-LINE HELICOBACTER PYLORI ERADICATION TREATMENTS IN SPAIN: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

H. pylori (Posters)  et al.

HOW TO ENHANCE A RESISTANCE OF GASTRIC MUCOSAL BARRIER IN PATIENTS WITH HELICOBACTER PYLORI ASSOCIATED CHRONIC GASTRITIS AND CONCOMITANT TYPE 2 DIABETES MELLITUS?
HOW TO ENHANCE A RESISTANCE OF GASTRIC MUCOSAL BARRIER IN PATIENTS WITH HELICOBACTER PYLORI ASSOCIATED CHRONIC GASTRITIS AND CONCOMITANT TYPE 2 DIABETES MELLITUS?

H. pylori (Posters)  et al.

ACCURACY OF THE HELICOBACTER PYLORI DIAGNOSTIC TESTS IN PATIENTS WITH PEPTIC ULCER BLEEDING- THE RESULTS OF A NETWORK META-ANALYSIS
ACCURACY OF THE HELICOBACTER PYLORI DIAGNOSTIC TESTS IN PATIENTS WITH PEPTIC ULCER BLEEDING- THE RESULTS OF A NETWORK META-ANALYSIS

H. pylori (Posters)  et al.

EFFECTIVENESS OF SECOND-LINE HELICOBACTER PYLORI ERADICATION TREATMENTS IN SPAIN: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
EFFECTIVENESS OF SECOND-LINE HELICOBACTER PYLORI ERADICATION TREATMENTS IN SPAIN: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

H. pylori (Posters)  et al.

NRF2 ROLE AND TARGETING IN HELICOBACTER PYLORI-INDUCED GASTRIC CARCINOGENESIS
NRF2 ROLE AND TARGETING IN HELICOBACTER PYLORI-INDUCED GASTRIC CARCINOGENESIS

H. pylori (Posters)  et al.

MANAGEMENT OF HELICOBACTER PYLORI INFECTION AT THE PRIMARY CARE LEVEL: EVALUATION OF DIFFERENT STRATEGIES TO IMPROVE ITS APPROACH
MANAGEMENT OF HELICOBACTER PYLORI INFECTION AT THE PRIMARY CARE LEVEL: EVALUATION OF DIFFERENT STRATEGIES TO IMPROVE ITS APPROACH

H. pylori (Posters)  et al.

LUMINAL NITRIC OXIDE IS INCREASED IN HELICOBACTER PYLORI-INDUCED GASTRIC INFLAMMATION AND RELATED TO VIRULENCE FACTORS OF THE BACTERIUM
LUMINAL NITRIC OXIDE IS INCREASED IN HELICOBACTER PYLORI-INDUCED GASTRIC INFLAMMATION AND RELATED TO VIRULENCE FACTORS OF THE BACTERIUM

H. pylori (Posters)  et al.

IMPACT OF HELICOBACTER PYLORI INFECTION ON COLORECTAL CANCER AND ADENOMA FREQUENCY
IMPACT OF HELICOBACTER PYLORI INFECTION ON COLORECTAL CANCER AND ADENOMA FREQUENCY

H. pylori (Posters)  et al.

Item 1 - 20 / 36
1
2